TOX 4- Pharmacology of chelators Flashcards
chelators
- DIMERCAPROL (2,3-dimercaptopropanol, BAL, dithiol chelator)
- SUCCIMER (dimercaptosuccinic acid, DMSA)- water soluble forms of dimercaprol
- DMPS (dimercaptopropan-sulfonic acid) - water soluble forms of dimercaprol
- PENICILLAMINE (d-dimethylcysteine) - water soluble derivative of penicillin, orally administered
- EDTA CALCIUM DISODIUM (ethylenediaminetetraacetic acid, EDTA)
- DEFEROXAMINE
mechanism of action- DIMERCAPROL (2,3-dimercaptopropanol, BAL, dithiol chelator)

DIMERCAPROL Pharmacokinetic characteristic
- not stabile in water, dispensed in peanut oil, given always im. !!!
- good permeability
- advantage - binds intracellular located cations
- disadvantage – promotes their infiltration from extracellular compartment into the tissues - excretion by kidney (6-8 hours)
DIMERCAPROL
- not stabile in water, dispensed in peanut oil, given always im. !!!
adv and disadv of dimercaprol
good permeability
- advantage - binds intracellular located cations
- disadvantage – promotes their infiltration from extracellular compartment into the tissues - excretion by kidney (6-8 hours)
dimercaprol excretion by
- excretion by kidney (6-8 hours)
Therapeutical indication dimercaprol
- acute arsenic
- inorganic mercury,
- gold,
- bismuth,
- antimony
- severe lead intoxication (together with NaCaEDTA)
- Special indication: encephalopathy induced by inorganic lead or bismuth
Adverse effects- dimercaprol
- nausea,
- vomiting,
- hypertension,
- tachycardia,
- fever pain,
- hematoma on the site if injection (thrombocytopenia, increased prothrombin time)
Special Indication of dimercaprol
lead or bismuth induced encephalopathy
SUCCIMER (dimercaptosuccinic acid, DMSA)
DMPS (dimercaptopropan-sulfonic acid)
Pharmacokinetic characteristic
- Water soluble forms of dimercaprol
- oral administration (DMPS also parenterally) -
- disadvantage moderate intracellular distribution
- advantage less adverse effect - faster excretion
water soluble forms of dimercaprol
SUCCIMER (dimercaptosuccinic acid, DMSA)
DMPS (dimercaptopropan-sulfonic acid)
how is SUCCIMER (dimercaptosuccinic acid, DMSA) administered
oral administration only
how is DMPS (dimercaptopropan-sulfonic acid) administered
- oral administration and
- parenterally (DMPS only)
SUCCIMER (dimercaptosuccinic acid, DMSA)
DMPS (dimercaptopropan-sulfonic acid)
adv and disadv
disadvantage moderate intracellular distribution
advantage less adverse effect - faster excretion
SUCCIMER (dimercaptosuccinic acid, DMSA) DMPS (dimercaptopropan-sulfonic acid) used for
for
- acute arsenic and mercury (effective only for some hours after intoxication),
- lead poisoning but not in encephalopathy
SUCCIMER (dimercaptosuccinic acid, DMSA) DMPS (dimercaptopropan-sulfonic acid) adverse effects
– better tolerated than dimercaprol
- nausea, vomiting, diarrhea,
- mild/moderate neutropenia
PENICILLAMINE (d-dimethylcysteine) chelator administration
water soluble derivative of penicillin, orally administered
PENICILLAMINE (d-dimethylcysteine) used for
Used for
- copper intoxication (Wilson’s disease)
- rheumatoid arthritis
adverse effects of penicillamine
- hypersensitive reactions in case of long-term treatment
- autoimmune reactions
- B6 vitamin depletion
EDTA CALCIUM DISODIUM (ethylenediaminetetraacetic acid, EDTA) used for
Used for lead poisoning (binds other cations as well)
Pharmacokinetic characteristic EDTA calcium disodium
- no absorption from the GI
– administration - slow iv. infusion for 5 days
- distribution only in the extracellular compartment
- fast excretion by kidney (glomerular filtration)
EDTA administration
administration - slow iv. infusion for 5 days
EDTA distributes only in
- distribution only in the extracellular compartment
- fast excretion by kidney (glomerular filtration)
EDTA Ca disodium excreted by
fast excretion by kidney (glomerular filtration)
adverse effects of EDTA
Adverse effects nephrotoxicity (rarely)
DEFEROXAMINE used for
Used for
- iron poisoning
- hemosiderosis,
- thalassemia
- Aluminum toxicity in kidney failure
Pharmacokinetic characteristic - deferoxamine
- no absorption from the GI – administration iv. or im.
- excretion by kidney and partly by the bile
deferoxamine administration
- no absorption from the GI – administration
- iv. or
- im.
Excretion of deferoxamine
- excretion by
- kidney and
- partly by the bile
Adverse effects deferoxamine
- idiosyncratic reactions
- acute respiratory distress syndrome
- neurotoxicity